Companies
/Healthcare
Pulmatrix Inc
$1.57
▼ $0.02 (−1.26%) today
Markets open · 3:15pm ET
Fundamentals
Market Cap
$5.9M
Revenue (TTM)
$3,000
EPS (TTM)
$-1.10
52-Week Range
$1 – $6
Street Target
$10.00
About Pulmatrix
Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company is headquartered in Lexington, Massachusetts.